Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment

.blurhash-client-img { display: none !important; }

Open Access

|Mar 2019

Authors

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Clinical Institute of Occupational Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2019-0009 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Language: English

Page range: 96 - 104

Submitted on: Jan 9, 2019

Accepted on: Jan 25, 2019

Published on: Mar 3, 2019

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2019 Barbara Senk, Katja Goricar, Viljem Kovac, Vita Dolzan, Alenka Franko, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.